Lonnie Lybarger

Title: The Innovative Contributions of Lonnie Lybarger

Introduction

Lonnie Lybarger is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of immunology through his innovative patent. His work focuses on the development of disulfide trap MHC class I molecules, which have important applications in vaccination and T cell tracking.

Latest Patents

Lybarger holds a patent for a disulfide trap, which comprises an antigen peptide covalently attached to an MHC class I heavy chain molecule by a disulfide bond extending between two cysteines. This invention allows for the proper oxidation of the disulfide trap in the endoplasmic reticulum, enabling recognition by T cells. The disulfide trap can be utilized for vaccination purposes, eliciting CD8 T cells, and in multivalent MHC/peptide reagents for the enumeration and tracking of T cells. Additionally, nucleic acids encoding a disulfide trap can be used as DNA vectors for vaccines.

Career Highlights

Lonnie Lybarger is affiliated with Washington University, where he continues to advance his research in immunology. His innovative approach to MHC class I molecules has opened new avenues for vaccine development and T cell research.

Collaborations

Lybarger has collaborated with notable colleagues such as Ted H Hansen and Daved Henry Fremont, contributing to the advancement of their shared research interests.

Conclusion

Lonnie Lybarger’s work exemplifies the impact of innovative thinking in the field of immunology. His patent on disulfide trap MHC class I molecules represents a significant advancement in vaccine technology and T cell research.